Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

YuMei Duan

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Oncogene|November 8, 2024
Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancerMing Wen, Yanfang Qiu, Meng Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2021
Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage RepairYanfang Qiu, Wenfeng Hu, Ming Wen, et al.
Cell Death & Disease|March 10, 2017
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cellsYouxiang Hou, Qianling Zhu, Zheng Li, et al.
Oncogene|March 12, 2022
SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signalingZhuoxian Rong, Lu Zhang, Zhi Li, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Oncogene|November 8, 2024
Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancerMing Wen, Yanfang Qiu, Meng Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2021
Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage RepairYanfang Qiu, Wenfeng Hu, Ming Wen, et al.
Cell Death & Disease|March 10, 2017
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cellsYouxiang Hou, Qianling Zhu, Zheng Li, et al.
Oncogene|March 12, 2022
SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signalingZhuoxian Rong, Lu Zhang, Zhi Li, et al.
Pageof 5